Dan Nabriski

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

Diabetes Management, Urology, Medicine +11

Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor.

Alan Laurence Saperstein, HOWARD BRAND, Tapan Audhya et al. · Endocrinology · 1992 · 82 citations

Immunology, Immunologic Mechanism, Immunotherapy +18

The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation

Elena Shinderman‐Maman, Keren Cohen, C Weingarten et al. · Oncogene · 2015 · 73 citations

Mapk-dependent Proliferation, Thyroid Disease, Gene Transcription +8

Prevalence and Evaluation of B12 Deficiency in Patients with Autoimmune Thyroid Disease

R. Ness-Abramof, Dan Nabriski, Menachem S. Shapiro et al. · The American Journal of the Medical Sciences · 2006 · 64 citations

Autoimmune Disease, Allergy, Thyroid Disease +9